ClinicalTrials.gg
RecruitingNCT06471439COPDUpdated Jun 24, 2024

An Investigation of Different Type Single Limb Exercise Training Effects in Copd

An interventional study of single leg exercise intervantion in COPD in Exercise, sponsored by Hacettepe University. Recruiting at 1 site in Turkey. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2024-06-24.

Primary conditionPulmonary Disease, Chronic ObstructiveRegistry: Motor ActivityReclassifiedWhy we changed it
Registry
Motor Activity — the first condition term the registry derived for this study.
ClinicalTrials.gg
Pulmonary Disease, Chronic Obstructive
Why
  1. Motor Activity is a broad heading, used only when no more specific condition is named.
  2. The study's title name Pulmonary Disease, Chronic Obstructive.
Confidence
High: the new condition is named in the study's own title. Of 46 hand-checked studies reclassified this way, 72% were exactly right and 89% in the right disease family; the registry's first term was right for 4% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Hacettepe University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by Jan 2025, 1 year 10 months ago, but the record still lists the study as recruiting.
  • Registered 11 months after the study started (first participant enrolled Jun 2023, registered May 2024).
  • Started Jun 2023; still recruiting 3 years 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
40 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 18 studies in Pulmonary Disease, Chronic Obstructive by Hacettepe University — 10 open to participants now, 12 under way, none of them phase 3. Pulmonary Disease, Chronic Obstructive · Hacettepe University.

Started
2023
with 1 other
No phase
6 of 18
2 open now
Primary completion
2025-01
later than 2 of 11 live
Registered
8th of 18
by date

Among the 18 studies in Pulmonary Disease, Chronic Obstructive by Hacettepe University, this one is one of 2 that started in 2023, is one of 6 with no phase, reaches primary completion later than 2 of the 11 other live ones, and was the 8th registered.

Pulmonary Disease, Chronic Obstructive

5,529 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 858 are open to participants now.

Browse Pulmonary Disease, Chronic Obstructive studies →

Open to participants now

10 of the 18 studies in Pulmonary Disease, Chronic Obstructive by Hacettepe University are open now, in 1 country. Recruiting first, the newest first:

4 more — sign in →

By country, each count listing its studies:

All 10 open studies →

Where they have run

Who these studies take

Of the 560 Pulmonary Disease, Chronic Obstructive studies recruiting now, 307 (55%) set no upper age limit and 82 (15%) stop at 75 or younger; 30 take children under 18; 88 take healthy volunteers.

This study: 40 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies in Pulmonary Disease, Chronic Obstructive by Hacettepe University, or all of them as a file.
02

Study summary

COPD presents not only respiratory symtoms but also vascular or muscle dysfunction. Exercise limitation is observed in COPD. Especially, decreased exercise performance related to vascular and fatique in quadriceps muscle. Exercise training is important for aerobic performance increasing. Generally results show exercise training with both lower limb. Increaed arterial stiffness and fatigue are observed in COPD. One leg exercise training result is not enough to highlight these parameters.

Three types single leg exercise intervantion will be applied. Exercise capacity, muscle strength, lung function, electromyography, lactate and quality of life will be measured.

Read the detailed description

Three types single leg exercise intervantion will applied to COPD patients that devided three groups. One leg continuous exercise training will be aplied to one group. One leg HIIT exercise training will be aplied to other group. One leg resistance exercise training will be aplied to the last group.

Exercise capacity and muscle strength are assesed. Lung function is measured. Electormyography is recorded. Lactate and quality of life are measured.

03

Conditions studied

  • Exercise

Browse trials for

Keywords

  • Chronic Obstructive Pulmonary Disease
  • Single Limb exercise
  • resistance training
  • continous exercise training
  • high intensity exercise training
04

In context

Pulmonary Disease, Chronic Obstructive Reclassified

5,529 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 858 are open to participants now.

This study's planned enrollment of 66 is close to the median of 62 across 3,847 interventional studies indexed under Pulmonary Disease, Chronic Obstructive.

Browse Pulmonary Disease, Chronic Obstructive studies →

Lead sponsor

Hacettepe University is the lead sponsor of 1,009 studies on the registry; 214 are open to participants now.

Compared within Pulmonary Disease, Chronic Obstructive, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Motor Activity. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patients that applied to physiotherapy
  • Cooperation for tests
  • without severe ortopedical and neurological disease
  • without severe cardiovascular disease
  • To volunteer for the study.

Exclusion criteria

Exclusion Criteria:

  • have an acute exacerbation or having exacerbation at last month
  • hypoxemia (PaO2\<55mmHg)
  • no cooperated to test without volunteer to study having ortophedical and neurological diesase that affecting of tests severe cardiovascular disease
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

06

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
66 participants (estimated)

Study arms

  • Active comparator
    single leg resistance exercise intervantion in COPD

    single leg resistance exercise intervantion in COPD will be perfomed at six weeks

    Other: single leg exercise intervantion in COPD

  • Active comparator
    single leg continous exercise intervantion in COPD

    single leg continous exercise intervantion in COPD will be perfomed at six weeks

    Other: single leg exercise intervantion in COPD

  • Active comparator
    single leg high intensity exercise intervantion in COPD

    single leg high intensity exercise intervantion in COPD will be perfomed at six weeks

    Other: single leg exercise intervantion in COPD

Interventions

  • Othersingle leg exercise intervantion in COPD

    single leg exercise intervantions 1. high intensity interval training 2. continous exercise training 3. resistance exercise training

    Also known as: single leg exercise intervantion

07

What researchers measure

Primary outcomes

  1. six minute walk test

    six minute walk test in meter

    Time frame: pre-intervention

Secondary outcomes

  1. cardiopulmonary exercise test

    VO2 as ml/kg/min will be recorded from incremental cycle cpet test

    Time frame: beginning day 2

  2. one leg cardiopulmonary exercise test

    VO2 as ml/kg/min will be recorded from incremental cycle cpet test

    Time frame: beginning, day 3

  3. quadriceps muscle strength assesing (repeated measeure)

    quadriceps muscle 10 repeated max muscle strength will be recorded at kilogram,

    Time frame: beginning day 1 and last day

  4. isometrics quadriceps muscle strength assesing

    quadriceps muscle isometric muscle strength will be recorded at kilogram

    Time frame: beginning day 1 and last day

  5. lung function

    FEV1/FVC ratio in %

    Time frame: beginning day 1 and last day

  6. quality of life assesing

    total score in 0-100 range

    Time frame: beginning day 1 and last day

  7. arterial stiffness

    total vascular resitance, augmentation index @ 75 and pulse wave velocity wil be determined arterial stiffness

    Time frame: beginning day 2 and last day

  8. lactate measurement

    lactate in mmol

    Time frame: beginning day 2 and last day

  9. electromyography measurement

    precentage of maximum volunteer contraction) %MVC values will be presented muscle fatigue (median frequence) and activation will be shown electromyograpy (EMG)

    Time frame: beginning day 2 and last day

08

Study locations

1 of 1 sites recruiting
  • Elif Kocaaga
    Ankara, Turkey
    Recruiting
09

References and documents

Publications

  • Dolmage TE, Goldstein RS. Effects of one-legged exercise training of patients with COPD. Chest. 2008 Feb;133(2):370-6. doi: 10.1378/chest.07-1423. Epub 2007 Oct 9. PubMed 17925417 ↗
  • Evans RA, Dolmage TE, Mangovski-Alzamora S, Romano J, O'Brien L, Brooks D, Goldstein RS. One-Legged Cycle Training for Chronic Obstructive Pulmonary Disease. A Pragmatic Study of Implementation to Pulmonary Rehabilitation. Ann Am Thorac Soc. 2015 Oct;12(10):1490-7. doi: 10.1513/AnnalsATS.201504-231OC. PubMed 26291542 ↗
  • MacInnis MJ, Morris N, Sonne MW, Zuniga AF, Keir PJ, Potvin JR, Gibala MJ. Physiological responses to incremental, interval, and continuous counterweighted single-leg and double-leg cycling at the same relative intensities. Eur J Appl Physiol. 2017 Jul;117(7):1423-1435. doi: 10.1007/s00421-017-3635-8. Epub 2017 May 11. PubMed 28497384 ↗
10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2023 (actual). Primary completion is estimated for Jan 2025, 18 months after the start.

Of 1,099 non-industry interventional studies with no phase under Pulmonary Disease, Chronic Obstructive, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 18 months is below that.

Counting every sponsor, half of 1,187 studies reached it within 22 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
May 17, 2024
First posted
Jun 24, 2024
StartActual
Jun 16, 2023
Primary completionEst.
Jan 2, 2025
CompletionEst.
Jan 2, 2025
Last update
Jun 24, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 24, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06471439
Responsible party
Elif Kocaaga (principal investigator, Hacettepe University) — Principal investigator
First posted
Jun 24, 2024
Start date
Jun 16, 2023
Primary completion
Jan 2, 2025 (estimated)
Completion
Jan 2, 2025 (estimated)
Last update
Jun 24, 2024

Study contacts

elif kocaaga, Ms
Contact
elifkocaaga86@gmail.com
+903123052525
elif kocaaga, Ms
Contact
elifkocaaga86@hotmail.com
+903123052525
elif kocaaga, ms
principal investigator · Hacettepe University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion